[Preprint] Randomized trial: Arthritis drugs improve survival in critically ill patients with Covid-19

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report – medRxiv

Commentaries: Covid-19: Arthritis drugs improve survival in intensive care patients, shows study – The BMJ AND Arthritis drugs could help save lives of Covid patients, research finds – The Guardian AND Expert comment – Two potentially life-saving drugs for critically ill COVID-19 patients – London School of Hygiene & Tropical Medicine

Commentary on Twitter

Two rheumatoid arthritis drugs will now be used to treat the patients with severe covid-19 in intensive care, after new findings have shown that they significantly improve survival and cut the time spent in hospital by a week to 10 days https://t.co/cxNM64L5S6

— The BMJ (@bmj_latest) January 8, 2021